Big Pharma lobbyists exploit patients and doctors

 

Share

Ten years ago, when I was a health journalist, I was once contacted by lobbying company working for a large pharmaceuticals firm.

They asked me if I would be interested in travelling to Chicago to attend a cancer conference where, they said, the company was about to make an exciting and important announcement.    

Foolishly I accepted. The conference was fascinating, the hospitality generous – but the announcement which I was supposed to write about could not in any way be regarded as news.

I’m ashamed to say I still wrote about it – feeling some sense of misplaced obligation to my ‘hosts’.

I should never have done so but in the process learnt an important lesson about the way in which the medical lobbying industry works.

Of several hundred doctors, nurse leaders and pharmacists from the UK who were in Chicago that year almost all were also there at the largesse of the drugs industry.

And I heard the stories of the other places they had visited. The conferences held around world-famous golf courses, the meetings held in beach resorts.

Those involved, of course, said that the exchange of expertise that such conferences facilitated was invaluable.

But the reason why the drug companies picked up the bill was not that altruistic: they just wanted to sell more of their product, boost their profits and were using all the tools in the lobbying box to do so.

What the drug – and increasingly the medical devises - industry want is for the NHS to constantly ‘refresh’ the treatments that they offer patients with the newest, brightest techniques and drugs available.

But such new treatments often come at inflated prices and sometimes offer limited – or unproven - benefits over existing therapies.

For a long time the National Institute of Clinical Excellence has done a good job at objectively assessing claims made by drugs companies and making recommendations for what should and what should not be available on the NHS.

But they have been fighting an uphill struggle. Every time they turn down a drug its manufacturers fight a proxy battle using patients groups (which they often fund) and doctors (who may have been on similar trips to mine) to campaign for the ruling to be reversed.

Emotive stories appear in the press about thousands of women who were being condemned to death because of the failure of the Nice to approve this, that or the other drug.

Perhaps the lobbying industry’s greatest success has been the creation of the Cancer Drugs Fund – which allows drugs to escape Nice’s scrutiny – but still be prescribed on the NHS.

All of this explains why the revelations about industry’s involvement in NHS England’s plans for specialist commissioning matters.

With £12 billion to spend on specialist services – where the industry concentrates its research and resources – the organisation and everyone who works for it is a magnate for lobbyists.

They want access to doctors, policy makers and officials who will ultimately decide what gets spent where.

That is not necessarily a bad thing: just because an industry is lobbying for something doesn’t mean it’s wrong.

But it does mean all meetings, hospitality and potential clashes of interest of decision makers need to be registered and open to public scrutiny. That is not currently the case.

It also means that NHS England needs to be much more robust when dealing with umbrella groups claiming to represent patients and charities but who’s funding comes from industry.

Only then can we ensure that the NHS’s limited resources are spent in the interests of patients not of big business.

React Now

Latest stories from i100
Have you tried new the Independent Digital Edition apps?
iJobs Job Widget
iJobs General

Supply Teachers needed in Bolton!

£12000 - £24000 per annum: Randstad Education Manchester Secondary: Are you a ...

English Teacher

£120 - £130 per day: Randstad Education Luton: ENGLISH TEACHER REQUIREDWe are ...

Trainee / Experienced Recruitment Consultants

£20000 - £25000 per annum + OTE £40,000: SThree: SThree are a global FTSE 250 ...

Science Teacher

£6720 - £33600 per annum: Randstad Education Nottingham: We are currently recr...

Day In a Page

Read Next
A new app has been launched that enables people to have a cuddle from a stranger  

Will Cuddlr do for hugging what Tinder and Grindr did for sex?

Jessica Brown Jessica Brown
Retail store Joy has sparked a social media backlash with its response to a customer who said one of its cards is offensive to people with bipolar  

Hey Joy, mocking people with bipolar isn't funny — it's offensive

Ellabell Risbridger
A roller-coaster tale from the 'voice of a generation'

Not That Kind of Girl:

A roller-coaster tale from 'voice of a generation' Lena Dunham
London is not bedlam or a cradle of vice. In fact it, as much as anywhere, deserves independence

London is not bedlam or a cradle of vice

In fact it, as much as anywhere, deserves independence
Vivienne Westwood 'didn’t want' relationship with Malcolm McLaren

Vivienne Westwood 'didn’t want' relationship with McLaren

Designer 'felt pressured' into going out with Sex Pistols manager
Jourdan Dunn: Model mother

Model mother

Jordan Dunn became one of the best-paid models in the world
Apple still coolest brand – despite U2 PR disaster

Apple still the coolest brand

Despite PR disaster of free U2 album
Scottish referendum: The Yes vote was the love that dared speak its name, but it was not to be

Despite the result, this is the end of the status quo

Boyd Tonkin on the fall-out from the Scottish referendum
Manolo Blahnik: The high priest of heels talks flats, Englishness, and why he loves Mary Beard

Manolo Blahnik: Flats, Englishness, and Mary Beard

The shoe designer who has been dubbed 'the patron saint of the stiletto'
The Beatles biographer reveals exclusive original manuscripts of some of the best pop songs ever written

Scrambled eggs and LSD

Behind The Beatles' lyrics - thanks to Hunter Davis's original manuscript copies
'Normcore' fashion: Blending in is the new standing out in latest catwalk non-trend

'Normcore': Blending in is the new standing out

Just when fashion was in grave danger of running out of trends, it only went and invented the non-trend. Rebecca Gonsalves investigates
Dance’s new leading ladies fight back: How female vocalists are now writing their own hits

New leading ladies of dance fight back

How female vocalists are now writing their own hits
Mystery of the Ground Zero wedding photo

A shot in the dark

Mystery of the wedding photo from Ground Zero
His life, the universe and everything

His life, the universe and everything

New biography sheds light on comic genius of Douglas Adams
Save us from small screen superheroes

Save us from small screen superheroes

Shows like Agents of S.H.I.E.L.D are little more than marketing tools
Reach for the skies

Reach for the skies

From pools to football pitches, rooftop living is looking up
These are the 12 best hotel spas in the UK

12 best hotel spas in the UK

Some hotels go all out on facilities; others stand out for the sheer quality of treatments